Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Monday, August 22, 2011

The FDA and medical device industry prefer the "status quo" . . .

The link below is a good explanation of what the FDA and medical device industry plans to do -

Now is the time for public comment to FDA and your representatives in D.C. . . .

No comments:

Post a Comment